Australia markets closed

Starpharma Holdings Limited (SPL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.3850+0.0350 (+2.59%)
At close: 4:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2020
30/06/2019
30/06/2018
Total revenue
1,166
6,033
1,651
3,812
Cost of revenue
526
890
251
-
Gross profit
640
5,143
1,400
3,812
Operating expenses
Research development
14,989
14,808
10,454
10,576
Selling general and administrative
3,629
2,669
2,495
2,241
Total operating expenses
21,461
20,903
16,723
15,242
Operating income or loss
-20,821
-15,760
-15,323
-11,430
Total other income/expenses net
559
559
12
73
Income before tax
-19,245
-14,678
-14,254
-10,285
Income tax expense
0
0
0
0
Income from continuing operations
-19,245
-14,678
-14,254
-10,285
Net income
-19,245
-14,678
-14,254
-10,285
Net income available to common shareholders
-19,245
-14,678
-14,254
-10,285
Basic EPS
-
-0.04
-0.04
-0.03
Diluted EPS
-
-0.04
-0.04
-0.03
Basic average shares
-
372,232
371,293
370,137
Diluted average shares
-
372,232
371,293
370,137
EBITDA
-
-15,760
-15,323
-11,430